Increasing evidence indicated that tumor burden mutation (TMB) could affect the infiltration of CD8+ T cells, which was considered as significant elements in alleviating the prognosis of tumors (Rizvi et al., 2015; Cristescu et al., 2018). Here, CD8A is linked to neoplasm.